» Articles » PMID: 16735393

Chronic Kidney Disease Post-liver Transplantation

Overview
Date 2006 Jun 1
PMID 16735393
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Renal disease is a recognized complication of orthotopic liver transplantation (OLT). We aimed to determine the incidence of all stages of chronic kidney disease (CKD), as defined in the Kidney Disease Outcomes Quality Initiative Guidelines. We also wanted to determine the risk factors for development of CKD and its impact on patient survival.

Methods: All patients who underwent cadaveric OLT, from January 1993 until July 2004, were analysed. The glomerular filtration rate (GFR) was determined using the equation developed by the Modification of Diet in Renal Disease Study. Thirty potential risk factors were examined by univariate and multivariate ordinal logistic regression analysis. Kaplan-Meier survival analysis, the log-rank test and Cox regression analysis were performed to evaluate the survival data.

Results: A total of 230 patients were included (107 males and 123 females) with a mean age of 47.7 years (4.5-70.35). Mean follow-up was 5.57 years (0.53-16.5). The following was the 10 year cumulative incidence for each stage of CKD: 0/1, 9.61%; 2, 53.71%; 3, 56.77%; 4, 6.11%; 5, 2.62%. Female gender, age, pre-OLT proteinuria, lower GFR from 1 year and higher creatinine from 6 months were associated with progression of CKD. The use of tacrolimus had a favourable impact. A GFR <30 ml/min, the need for re-transplantation and fulminant hepatic failure were all associated with reduced patient survival.

Conclusions: Moderate CKD was very prevalent. We identified the risk factors for progression of CKD and also that severe CKD was associated with reduced patient survival.

Citing Articles

An Exercise and Wellness Behavior Change Program for Solid Organ Transplant: A Clinical Research Protocol for the Transplant Wellness Program.

Sim J, Perinpanayagam M, Bahry V, Wytsma-Fisher K, Burak K, Isaac D Can J Kidney Health Dis. 2024; 11:20543581241289196.

PMID: 39449962 PMC: 11500225. DOI: 10.1177/20543581241289196.


Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients.

Chiang H, Li L, Hsu C, Lin C, Chan Y, Wang C Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631002 PMC: 10457954. DOI: 10.3390/ph16081087.


Renal Dysfunction After Liver Transplant: Is CNI Nephrotoxicity Overrated.

Puri P, Bansal N J Clin Exp Hepatol. 2023; 13(4):556-558.

PMID: 37440945 PMC: 10333944. DOI: 10.1016/j.jceh.2023.05.005.


Albuminuria post-liver transplant is a predictor of kidney disease progression and mortality.

Ting J, Induruwage D, Yoshida E, Dhruve M, Zalunardo N Can Liver J. 2023; 6(1):2-13.

PMID: 36908578 PMC: 9997516. DOI: 10.3138/canlivj-2022-0019.


Kidney disease in non-kidney solid organ transplantation.

Swanson K World J Transplant. 2022; 12(8):231-249.

PMID: 36159075 PMC: 9453292. DOI: 10.5500/wjt.v12.i8.231.